Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-09-07
2009-06-16
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S397000, C514S414000, C514S418000, C544S373000, C548S312100, C548S465000
Reexamination Certificate
active
07547703
ABSTRACT:
The present invention relates to indolinone derivatives, substituted in the 6-position, of the formulain whichR1to R6and X are as defined in claim1, to their tautomers, enantiomers, diastereomers, to their mixtures and to their salts, in particular their physiologically acceptable salts, which have useful pharmacological properties, in particular in inhibiting action on various receptor tyrosine kinases and on the proliferation of endothelial cells and various tumour cells, to medicaments comprising these compounds, to their use and to processes for their preparation.
REFERENCES:
patent: 6762180 (2004-07-01), Roth et al.
patent: 6855710 (2005-02-01), Walter et al.
patent: 2006/0148883 (2006-07-01), Park et al.
patent: 2006/0194813 (2006-08-01), Heckel et al.
patent: 2 342 622 (2000-06-01), None
patent: 2 493 436 (2004-01-01), None
patent: 92/20642 (1992-11-01), None
patent: 99/10325 (1999-03-01), None
patent: 99/15500 (1999-04-01), None
patent: WO0056710 (2000-09-01), None
patent: 01/27080 (2001-04-01), None
patent: 01/27081 (2001-04-01), None
patent: WO0018734 (2002-04-01), None
patent: WO03026650 (2003-04-01), None
patent: WO03027102 (2003-04-01), None
patent: WO2004009547 (2004-01-01), None
International Search Report for Reference #PCT/EP03/07960.
International Search Report for PCT/EP03/07961 mailed Oct. 21, 2003.
International Search Report for PCT/EP2005/057013 mailed Feb. 23, 2006.
Charles Kuhn et al; The Roles of the Myofibroblast in Idiopathic Pulmonary Fibrosis; American Journal of Pathology (1991) vol. 138 No. 5 pp. 1257-1265.
H. Suzuki et al; Epidermal Growth Factor Receptor Tyrosine Kinase Inhibition Augments a Murine Model of Pulmonary Fibrosis; Cancer Research (2003) vol. 63 No. 16 pp. 5054-5059.
D.M. Lebensztejn; Reversibility of Advanced Liver Fibrosis-Therapeutic Possibility and Biochemical Monitoring of the Disease; Przegl Epidemiology (2005) vol. 59 No. 2 pp. 535-540.
Heckel Armin
Hilberg Frank
Kley Joerg
Lehmann-Lintz Thorsten
Roth Gerald Juergen
Boehringer Ingelheim Pharma GmbH & Co. KG
Lebel Edouard G.
Morris Michael P.
Saeed Kamal A
Wittmayer Paula K.
LandOfFree
Indoline derivatives substituted in the 6-position, their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Indoline derivatives substituted in the 6-position, their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indoline derivatives substituted in the 6-position, their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4092454